The rise of SGLT2 inhibitors: the time is now for cardiovascular specialists to lead the charge.
Norgard NB, Lopez-Candales A. The rise of SGLT2 inhibitors: the time is now for cardiovascular specialists to lead the charge. Postgrad Med. 2022 01; 134(1):11-13.